Cited by 642Blood Pressure and Hypertension StudiesHeart Rate Variability and Autonomic ControlCardiovascular and exercise physiology

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.

Open access
Esler, M, Jennings, G, Korner, P, Willett, I, Dudley, F, Hasking, G, Anderson, W, Lambert, G·1988·Hypertension

Abstract

KEY WORDS • norepinephrine kinetics • catecholamines • sympathetic nervous system hypertension • heart failure • cirrhosis S INCE the sympathetic nervous system has such a central place in homeostasis in general, and in circulatory adaptation in particular, it is paradoxical that so little is known about the possible contribution of disturbed sympathetic nervous function to the development of human diseases.Clinical tests of sympathetic nervous system activity have, by and large, been routinely applied in one setting only: the detection of sympathetic nervous failure, from autonomic insufficiency syndromes, in patients with postural hypotension.A list of "candidate" diseases for sympathetic nervous system dysfunction might include, for example, essential hypertension, cardiac failure, coronary artery spasm, cirrhosis, mitral valve prolapse, and Raynaud's syndrome.Until very recently, the picture of sympathetic nervous pathophysiology for conditions such as these was particularly sketchy, mainly because of the rudimentary nature of the tests of sympathetic nervous system function available to investigative clinical medicine.Pertinent questions have gone incompletely answered at best -questions such as: Is the sympathetic nervous system directly involved in the early pathogenesis of essential hypertension? 1 Is increased renal sympathetic activity a common cause of sodium retention in edematous states? 2 Is increased cardiac sympathetic nerve firing an important element in the development of cardiac arrhythmias in humans?

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.11.1.3

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Essential hypertension overall is characterized by ongoing sympathetic nervous system activation.

    “Perhaps the same might apply in essential hypertension, which overall is also characterized by ongoing sympathetic nervous system activation.22,23”
  • For cardiac sympathetic activation, the ranking is cardiac failure > normal-weight essential hypertension > depressive illness > aging.

    “The ranking is as follows: for cardiac sympathetic activation, cardiac failure>normal-weight essential hypertension>depressive ill ness>aging.19,22,24,42,44,45,49,78”
  • Circulating norepinephrine levels are only a minor fraction of the amount secreted from sympathetic nerve terminals, so plasma norepinephrine values may not reflect sympathetic neural drive and secretion.

    “First, circulating norepinephrine levels are only a minor fraction of the amount secreted from sympathetic nerve terminals27. As a result, plasma norepinephrine values may not reflect sympathetic neural drive and secrection of the neurotransmitter27,28.”
  • Subsequent studies employing microneurography or measurements of norepinephrine spillover in young adults with borderline or established hypertension have demonstrated marked sympathetic activation.

    “Subsequent studies employing microneurography or measurements of norepinephrine spillover in young adults with borderline or established hypertension have also demonstrated marked sympathetic activation28,32,33.”
  • The norepinephrine isotope dilution method permits precise quantification of the net release of norepinephrine from sympathetic nerves and the amount of norepinephrine undergoing clearance from the bloodstream.

    “This method permits precise quantification of the “net” release of the adrenergic neurotransmitter from sympathetic nerves and the amount of norepinephrine undergoing “clearance” from the bloodstream27,28.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 14

  1. Engelman K, Portnoy B, Sjoerdsma A. Plasma catechola- mine concentrations in patients with hypertension. Circ Res 1970;26,27(suppl I):I-141-I-145
  2. Cousineau D, Goresky CA, Bach GG, Rose CP. Effect of /3-adrenergic blockade on in vivo norepinephrine release in canine heart. Am J Physiol 1984;246:H283-H292
  3. Bufano G, Vaona G, Starcich R. Approach to the pharmaco- kinetics of DL-7-3 H-noradrenaline. Eur J Clin Pharmacol 1973;6:88-92
  4. Linares OA, Supiano MA, Morrow LA, Halter JB. Norepi- VOL. 11, No 1, JANUARY 1988 nephrine release and metabolism in the elderly by compart- mental analysis: relationship to dietary salt intake [Abstract]. Clin Res 1986;34:950A
  5. Kopin LI. Estimation of relative magnitudes of alternative metabolic pathways. In: GlickD, ed. Methods of biochemical analysis; vol XI. New York: Wiley and Sons, 1963:247-278
  6. Goodall MC, Kirshner N, Rosen L. Metabolism of noradren- aline in humans. J Clin Invest 1959;38:707-714
  7. Korner PI. Lntegrative neural cardiovascular control. Physiol Rev 1971;51:312-367
  8. Goldstein DS, Horwitz D, Keiser HR, Polinsky RJ, Kopin LI. Plasma /-[ 3 H]norepinephrine, d-[ 14 C]norepinephrine, and d,/-[ 3 H]isoproterenol kinetics in essential hypertension. J Clin Invest 1983;72:1748-1758
  9. Hoeldtke RD, Rogawski M, Wurtman RJ. Effect of selective destruction of central and peripheral catecholamine contain- ing neurons with 6-hydroxy dopamine on catecholamine ex- cretion in the rat. Br J Pharmacol 1974;50:265-270
  10. Linares O, SanfieldJ, Morrow L, Rosen S, VeithR, Halter J. Compartmental analysis: a new approach to norepinephrine' kinetics in man [Abstract]. Clin Res 1985;33:535A
  11. Hjemdahl P, Akerstedt T, Pollare T, Gillberg M. Influence of 0-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adren- aline during i.v. infusion. Acta Physiol Scand [Suppl] 1983; 515:45-53
  12. Esler M. The influence of aging on catecholamine metabo- lism. In: Amery A, Staessen J, eds. Hypertension in the elderly. Amsterdam: Elsevier, 1988 (Handbook of hyperten- sion; vol 11), in press
  13. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978;298: 1295-1301 121.
  14. Doidge JM, Satchell DG. Adrenergic and nonadrenergic in- hibitory nerves in mammalian airways. J Auton Nerv Syst 1982;5:83-99 131.

Cited by

Sorted by citations

Authors
Esler, M., Jennings, G., Korner, P., Willett, I., Dudley, F., Hasking, G., Anderson, W., & Lambert, G.
Affiliations
Baker Medical Research Institute, Prahran, Australia.
Venue
Hypertension
Published
1988-01
Volume
11
Issue
1
Pages
3-20
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W1973089615
Cited by
642
References
149
Citations by year
2026: 6 · 2025: 8 · 2024: 17 · 2023: 12 · 2022: 8 · 2021: 16 · 2020: 25 · 2019: 21 · 2018: 18 · 2017: 21 · 2016: 31 · 2015: 31 · 2014: 40 · 2013: 30 · 2012: 18
FWCI
8.23
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
sympathetic activity, norepinephrine turnover, norepinephrine kinetics, catecholamines, essential hypertension, heart failure, liver cirrhosis, sympathetic dysfunction, autonomic failure, orthostatic hypotension, cardiac arrhythmias, sodium retention
MeSH terms
Adrenal Medulla, Animals, Dogs, Heart Failure, Humans, Hypertension, Kidney, Liver Circulation, Liver Cirrhosis, Synaptic Transmission, Norepinephrine, Sympathetic Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review